201 related articles for article (PubMed ID: 15809748)
1. Urinary 8-hydroxy-2'-deoxyguanosine excretion as a biomarker for estimating DNA oxidation in patients undergoing external radiotherapy and/or brachytherapy.
Yamazaki H; Inoue T; Koizumi M; Tanaka E; Yoshioka Y; Nakamura H; Shuo X; Inoue T
Oncol Rep; 2005 May; 13(5):847-51. PubMed ID: 15809748
[TBL] [Abstract][Full Text] [Related]
2. Significance of the urinary 8-OHdG level as an oxidative stress marker in lung cancer patients.
Yano T; Shoji F; Baba H; Koga T; Shiraishi T; Orita H; Kohno H
Lung Cancer; 2009 Jan; 63(1):111-4. PubMed ID: 18676055
[TBL] [Abstract][Full Text] [Related]
3. Study of urinary 8-hydroxydeoxyguanosine as a biomarker of oxidative DNA damage in diabetic nephropathy patients.
Xu GW; Yao QH; Weng QF; Su BL; Zhang X; Xiong JH
J Pharm Biomed Anal; 2004 Sep; 36(1):101-4. PubMed ID: 15351053
[TBL] [Abstract][Full Text] [Related]
4. [Urinary 8-hydroxy-2'-deoxyguanosin (8-OHdG) in patients with chronic liver diseases].
Ishizakai M; Yoshida K; Nishimoto N; Saleh AM; Ishii C; Handa H; Ogawara H; Nagamine T; Murakami M; Murakami H
Rinsho Byori; 2004 Sep; 52(9):732-6. PubMed ID: 15552932
[TBL] [Abstract][Full Text] [Related]
5. [Assessment of 8-hydroxy-2'-deoxyguanosine concentrations in bladder cancer patients treated with intravesical BCG instillation].
Kaczmarek P; Błaszczyk J; Fijałkowski P; Sierakowska-Fijałek A; Niemirowicz J; Kasprzak A; Baj Z
Pol Merkur Lekarski; 2005 Oct; 19(112):526-8. PubMed ID: 16379317
[TBL] [Abstract][Full Text] [Related]
6. Oxidative DNA damage in patients with prostate cancer and its response to treatment.
Miyake H; Hara I; Kamidono S; Eto H
J Urol; 2004 Apr; 171(4):1533-6. PubMed ID: 15017214
[TBL] [Abstract][Full Text] [Related]
7. 8-hydroxy-2' -deoxyguanosine (8-OHdG): A critical biomarker of oxidative stress and carcinogenesis.
Valavanidis A; Vlachogianni T; Fiotakis C
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2009 Apr; 27(2):120-39. PubMed ID: 19412858
[TBL] [Abstract][Full Text] [Related]
8. Effect of repeated intravenous iron administration in haemodialysis patients on serum 8-hydroxy-2'-deoxyguanosine levels.
Maruyama Y; Nakayama M; Yoshimura K; Nakano H; Yamamoto H; Yokoyama K; Lindholm B
Nephrol Dial Transplant; 2007 May; 22(5):1407-12. PubMed ID: 17264097
[TBL] [Abstract][Full Text] [Related]
9. Significance of urinary excretion of 8-hydroxy-2'-deoxyguanosine in healthy subjects and liver disease patients.
Ichiba M; Yamada S; Ishii K; Gonda K; Murai R; Shimomura T; Saeki T; Kanbe T; Tanabe Y; Yoshida Y; Tsuchiya H; Hoshikawa Y; Kurimasa A; Kishimoto Y; Kawasaki H; Shiota G
Hepatogastroenterology; 2007 Sep; 54(78):1736-40. PubMed ID: 18019707
[TBL] [Abstract][Full Text] [Related]
10. Circadian variation in multiple sclerosis of oxidative stress marker of DNA damage. A potential cancer marker?
Kanabrocki EL; Ryan MD; Murray D; Jacobs RW; Wang J; Hurder A; Friedman NC; Siegel G; Eladasari B; Nemchausky BA; Cornelissen G; Halberg F
Clin Ter; 2006; 157(2):117-22. PubMed ID: 16817500
[TBL] [Abstract][Full Text] [Related]
11. Urinary 8-hydroxy-2'-deoxyguanosine (8-OHdG) and genetic polymorphisms in breast cancer patients.
Kuo HW; Chou SY; Hu TW; Wu FY; Chen DJ
Mutat Res; 2007 Jul; 631(1):62-8. PubMed ID: 17512776
[TBL] [Abstract][Full Text] [Related]
12. Sulfotransferase 1A1 and glutathione S-transferase P1 genetic polymorphisms modulate the levels of urinary 8-hydroxy-2'-deoxyguanosine in betel quid chewers.
Wong RH; Hu CW; Yeh CY; Chao MR; Chen CC; Huang JH; Chang SH; Lee SI; Lee HS
Arch Toxicol; 2008 May; 82(5):313-21. PubMed ID: 17912498
[TBL] [Abstract][Full Text] [Related]
13. Increased urinary 8-hydroxy-2'-deoxyguanosine excretion in long-distance bus drivers in Taiwan.
Han YY; Donovan M; Sung FC
Chemosphere; 2010 May; 79(9):942-8. PubMed ID: 20303570
[TBL] [Abstract][Full Text] [Related]
14. Organochlorines and 8-hydroxy-2'-deoxyguanosine (8-OHdG) in cancerous and noncancerous breast tissue: do the data support the hypothesis that oxidative DNA damage caused by organochlorines affects breast cancer?
Charles MJ; Schell MJ; Willman E; Gross HB; Lin Y; Sonnenberg S; Graham ML
Arch Environ Contam Toxicol; 2001 Oct; 41(3):386-95. PubMed ID: 11503078
[TBL] [Abstract][Full Text] [Related]
15. Urinary 8-hydroxydeoxyguanosine levels as a biomarker for progression of Parkinson disease.
Sato S; Mizuno Y; Hattori N
Neurology; 2005 Mar; 64(6):1081-3. PubMed ID: 15781836
[TBL] [Abstract][Full Text] [Related]
16. Gender- and age-related distinctions for the in vivo prooxidant state in Fanconi anaemia patients.
Pagano G; Degan P; d'Ischia M; Kelly FJ; Pallardó FV; Zatterale A; Anak SS; Akisik EE; Beneduce G; Calzone R; De Nicola E; Dunster C; Lloret A; Manini P; Nobili B; Saviano A; Vuttariello E; Warnau M
Carcinogenesis; 2004 Oct; 25(10):1899-909. PubMed ID: 15192013
[TBL] [Abstract][Full Text] [Related]
17. Analysis of oxidative stress expressed by urinary level of 8-hydroxy-2'-deoxyguanosine and biopyrrin in atrial fibrillation: effect of sinus rhythm restoration.
Toyama K; Yamabe H; Uemura T; Nagayoshi Y; Morihisa K; Koyama J; Kanazawa H; Hoshiyama T; Ogawa H
Int J Cardiol; 2013 Sep; 168(1):80-5. PubMed ID: 23040081
[TBL] [Abstract][Full Text] [Related]
18. Urinary level of nickel and acute leukaemia in Chinese children.
Yang Y; Jin XM; Yan CH; Tian Y; Tang JY; Shen XM
Toxicol Ind Health; 2008 Oct; 24(9):603-10. PubMed ID: 19106127
[TBL] [Abstract][Full Text] [Related]
19. Urinary 8-hydroxydeoxyguanosine and urothelial carcinoma risk in low arsenic exposure area.
Chung CJ; Huang CJ; Pu YS; Su CT; Huang YK; Chen YT; Hsueh YM
Toxicol Appl Pharmacol; 2008 Jan; 226(1):14-21. PubMed ID: 17950770
[TBL] [Abstract][Full Text] [Related]
20. Urinary excretion of 8-hydroxydeoxyguanosine and malondialdehyde after high dose radiochemotherapy preceding stem cell transplantation.
Bergman V; Leanderson P; Starkhammar H; Tagesson C
Free Radic Biol Med; 2004 Feb; 36(3):300-6. PubMed ID: 15036349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
